Longevity Companies Directory
🏢 Explore 1,000+ Longevity Innovators
Welcome to the definitive index of companies extending human healthspan and lifespan.
From gene therapy labs to age-reversal biotech, from AI-powered diagnostics to metabolic supplement brands—this is your portal into the real-world builders of the longevity revolution.
Whether you’re an investor, researcher, health enthusiast, or just longevity-curious, this page helps you navigate the most active companies in the field.
🔍 Search & Filter
Use the smart filters below to quickly sort and explore:
- By Intervention Type:
Senolytics, mTOR inhibitors, NAD⁺ boosters, Partial Reprogramming, Stem Cell Therapies, Aging Clocks, and more. - By Hallmark of Aging:
Targeting telomere attrition, mitochondrial dysfunction, cellular senescence, loss of proteostasis, etc. - By Modality:
Drug, Diagnostic, Supplement, Device, Platform, AI Tool, CRO - By Stage:
Preclinical, Phase I, Phase II, Phase III, Commercial - By Location:
North America, Europe, Asia-Pacific, Global - By Business Type:
B2B, B2C, Nonprofit, Research Lab - By Funding Level:
Bootstrapped, Seed, Series A, Series B+, Public
🗂️ Company Card Preview (List/Grid Format)
Each company includes:
- ✅ Name + logo
- 🧠 1–2 sentence description
- 🌍 HQ Location
- 🧬 Intervention types & aging targets
- 💰 Funding stage + known investors
- 🔗 Website + Linked trials or publications
- 🔄 Tags: “Featured in Trial Tracker”, “Toolbox Reviewed”, “Top 100”
- ⭐ Bookmark or save to Dashboard
👉 [Explore Company] button leads to dedicated profile page
🌟 Featured Spotlight Companies
(Rotating or manually curated)
Highlight:
- Top funded
- Newcomers to watch
- Most active in trials
- Most cited in publications
📥 Add or Update a Listing
Think your company belongs here—or needs an update?
👉 [Submit a New Company]
👉 [Claim this Profile]
(Moderated for accuracy. Response within 72 hours.)
🔔 Stay Updated
This directory is constantly expanding as the longevity landscape evolves.
👉 [Join the Newsletter] to receive featured company breakdowns, funding alerts, and breakthrough profiles each month.
